Monoclonal Antibodies: A Review

2017360 citationsReview

Authors

Surjit Singh · All India Institute of Medical Sciences Jodhpur

Nitish K. Kumar · All India Institute of Medical Sciences Jodhpur

Pradeep Dwiwedi · All India Institute of Medical Sciences Jodhpur

Jaykaran Charan · All India Institute of Medical Sciences Jodhpur

Rimple Jeet Kaur · All India Institute of Medical Sciences Jodhpur

Preeti Sidhu · All India Institute of Medical Sciences Jodhpur

Abstract

With the advent of fully human MAbs, the efficacy and safety have improved in the treatment of various cardiovascular, cancer, respiratory, hematology, autoimmune diseases and infections. The introduction of biosimilars will increase the affordability and utilization of MAbs in the treatment of various diseases.

Topics & Keywords

Biological Research and Disease Studies Monoclonal and Polyclonal Antibodies Research Cancer Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Clinical Pharmacology

Volume 13, Issue 2, pp. 85-99

DOI: 10.2174/1574884712666170809124728

Field-Weighted Citation Impact: 12.20